Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

30 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/30/3211377/0/en/SciSparc-Neurothera-Labs-Granted-Patent-by-Israeli-Patent-Office-for-its-Proprietary-Opioid-Based-Patent-Family-to-Enhance-Pain-Relief-and-Reduce-Side-Effects.html

01 Dec 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/scisparc-acquires-xylo-technologies-innovative-endoscopic-portfolio-18413

26 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/26/3195068/0/en/SciSparc-to-Acquire-Treasury-of-Patents-for-Innovative-Medical-Endoscopy-Systems.html

20 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/20/3191728/0/en/SciSparc-Neurothera-Labs-Announces-Israeli-Patent-Application-in-Collaboration-with-Clearmind-Medicine-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189045/0/en/Clearmind-Medicine-Files-Israeli-Patent-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

24 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/24/3172747/0/en/SciSparc-Announces-Closing-of-the-Acquisition-of-a-Publicly-Traded-Company-on-the-TSXV-to-which-it-transferred-its-Advanced-Clinical-Stage-Pharmaceutical-Portfolio.html
ABOUT THIS PAGE